Construction Start of Eli Lilly's New Facility Before 2026 | Binary | | | 7 months ago | |
Eli Lilly Market Share by End of 2026 | Categorical | | | 7 months ago | |
Completion of New Facility on Schedule by 2028 | Categorical | | | 7 months ago | |
Revenue from New Drugs in First Year After Release | Categorical | | | 7 months ago | |
FDA Approval for Mounjaro by end of 2025 | Binary | | | 7 months ago | |
Will Eli Lilly publish comprehensive clinical trial data on donanemab by March 2025? | Binary | | | 2 months ago | |
Will the NHS offer donanemab for Alzheimer's prevention by June 2025? | Binary | | | 2 months ago | |
FDA Approval for Zepbound by end of 2025 | Binary | | | 7 months ago | |
How will Eli Lilly's stock price react within a week of UK MHRA's decision on donanemab? | Categorical | | | 2 months ago | |
Will donanemab be approved by the UK MHRA for Alzheimer's prevention by end of 2024? | Binary | | | 2 months ago | |
What will be the outcome of Eli Lilly's negotiations with the UK government on donanemab by end of 2024? | Categorical | | | 2 months ago | |
How many countries will approve donanemab for Alzheimer's prevention by end of 2025? | Categorical | | | 2 months ago | |